(Q39558945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

The airways, a novel route for delivering monoclonal antibodies to treat lung tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Nicolas Congy-Jolivet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Pascale Reverdiau

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Gilles Paintaud

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Agnès Maillet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Laurent Guilleminault

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Etienne Lemarié

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Stéphanie Lerondel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Nicolas Azzopardi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jérôme Montharu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Brigitte Legrain

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Christelle Parent

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Dominique-Henri Douvin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

José Hureaux

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Michèle De Monte

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Patrice Diot

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Alain Le Pape

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Hervé Watier

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Nathalie Heuzé-Vourc'h

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

14 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

2147-2156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21491145%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

The place of targeted therapy in the patient management of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

21 January 2018

Aerosolized chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Immunotherapy in metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

mAbs: a business perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Global antibody development trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

The biological properties of cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Cetuximab in combination therapy: from bench to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Aerosol delivery of chemotherapy in an orthotopic model of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Preclinical development of monoclonal antibodies: considerations for the use of non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

The lungs as a portal of entry for systemic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

In vivo animal models for drug delivery across the lung mucosal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Noninvasive tracking of donor cell homing by near-infrared fluorescence imaging shortly after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Drug resistance and the solid tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Inhaling medicines: delivering drugs to the body through the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Monomeric Fc fusions: impact on pharmacokinetic and biological activity of protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0442-5

Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

21 January 2018

1 reference

12 December 2020

Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation

1 reference

12 December 2020

Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.

1 reference

12 December 2020

Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies

1 reference

12 December 2020

Non-invasive pulmonary aerosol delivery in mice by the endotracheal route

1 reference

12 December 2020

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab

1 reference

12 December 2020